SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-021860
Filing Date
2023-02-14
Accepted
2023-02-14 16:52:48
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236168d13_sc13ga.htm SC 13G/A 57709
  Complete submission text file 0001104659-23-021860.txt   59271
Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Subject) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92874 | Film No.: 23630947
SIC: 2834 Pharmaceutical Preparations